This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Physicians Overprescribe Antibiotics for Children’s Sore Throats
    Physicians prescribe antibiotics for more than half of children with sore throat, exceeding the expected prevalence of strep throat, and used non-recommended antibiotics for 27 percent of children who received an antibiotic prescription, according to a study in the Nov. 9, ...More
    November 8, 2005 Posted in News
  • Growing Antibacterial Resistance Set to put Antibiotic R&D Back in Vogue
    LONDON -- A new report suggests that growing antibacterial resistance is set to put antibiotic R&D back in vogue. A highly competitive, over-saturated market awash with generics. Often long and tortuous development times, with less than impressive return on investments. ...More
    October 19, 2005 Posted in News
  • TB Alliance and Bayer Launch Historic Global Drug Trials for Tuberculosis
    NEW YORK, and LEVERKUSEN, Germany -- The Global Alliance for TB Drug Development (TB Alliance) and Bayer Healthcare AG today announced a partnership to coordinate a global clinical trial program to study the potential of an existing antibiotic, moxifloxacin, to shorten the ...More
    October 17, 2005 Posted in News
  • Researcher Leads Two International Studies of Antibiotic as New Treatment for Tuberculosis
    A Johns Hopkins infectious disease expert will lead two international studies of the effectiveness of the antibiotic moxifloxacin as a new treatment for tuberculosis, the highly contagious bacterial disease that kills more than 2 million people worldwide each year and is ...More
    October 17, 2005 Posted in News
  • Probiotics Symposium Focuses on Children's Health
    WASHINGTON, D.C. -- Leading pediatricians are learning that "good" bacteria, or probiotics, can have an effect on different gastrointestinal disorders, including diarrhea and bacterial infections and help the balance of bacteria in the digestive tract of pediatric patients. ...More
    October 10, 2005 Posted in News
  • Oral Zyvox Shows Cost Savings for Treatment of Skin Infections
    Oral Zyvox (linezolid) was associated with significant savings to the healthcare system – an average of $4,630 per patient – compared to vancomycin when used in an outpatient setting for people with certain infections, according to data to be presented today at the ...More
    October 7, 2005 Posted in News
  • Toronto Public Health Officials Identify Illness That Killed 16 Nursing Home Residents
    Dr. David McKeown, medical officer of Toronto’s department of health, reports that officials have identified Legionnaire’s disease as the mystery illness that killed 16 elderly residents of a nursing home in Toronto. According to McKeown, laboratory testing on autopsy ...More
    October 7, 2005 Posted in News
  • Antibiotic Resistance Markers in Genetically Modified Plants Not a Risk to Human Health
    Antibiotic-resistance markers in genetically modified (GM) plants do not pose a substantial risk to human health, concludes a review article published in the October issue of The Lancet Infectious Diseases. Antibiotic resistance marker genes are used as a tool to recognize ...More
    September 27, 2005 Posted in News
  • Scientists Design Method to Fight Implant Infections
    Infections associated with inserting a medical device can be devastating, painful, and cause prolonged disability, costing tens of thousands of dollars. Now, researchers at Jefferson Medical College have found a way to create a permanent chemical bond between antibiotics ...More
    September 25, 2005 Posted in News
  • New Treatment Option for Childhood Cholera
    Researchers in Bangladesh have found that severe cholera in children can be treated effectively with a single dose of the antibiotic ciprofloxacin, according to a study published online by The Lancet. Cholera is a major global health problem particularly in children in ...More
    September 14, 2005 Posted in News